Jun 06, 2019 / 08:00PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
So we're going to go ahead and get started. Thanks. Good afternoon. Welcome to the Jefferies 2019 Global Healthcare Conference. I'm Brandon Couillard, cover the life science tools. Here from the company, CEO, Mr. Frank Laukien, as well as Juergen Srega, who runs the Daltonics Division for Bruker as well just coming out of very important ASMS Conference earlier this week and look forward to hearing some of your feedback from that show. Frank will make some opening remarks, and then we'll have a little fireside chat. There will be a breakout room downstairs in Broadway afterwards. And I'll turn it over to Frank.
Frank H. Laukien - Bruker Corporation - Chairman, CEO & President
Thank you. Thank you so much for having us, Brandon, and thank you for sticking around after 4:00. Pleasure to be here again. So maybe 2 topics starting out with Q1 and our longer-term outlook. We had a good Q1. We did raise our guidance incrementally to 4.5% to 5.5% organic growth and our operating margin expansion
Bruker Corp at Jefferies Healthcare Conference Transcript
Jun 07, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers